Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
Myelo Therapeutics has raised $17.4M in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Myelo Therapeutics's investors include IBB Ventures, European Commission.
Myelo Therapeutics is headquartered in Berlin, Germany.
Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
Myelo Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myelo Therapeutics — Funding & Investors." VCBacked, August 4, 2022, https://www.vcbacked.co/company/myelo-therapeutics. Accessed November 12, 2026.
VCBacked. (2022). Myelo Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/myelo-therapeutics
{{cite web |title=Myelo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/myelo-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Myelo Therapeutics? Request a listing update